高补体C4基因拷贝数是巨细胞动脉炎和IgA血管炎共享的遗传风险因素
该研究基于3498例巨细胞动脉炎(GCA)、284例IgA血管炎(IgAV)和16867例对照的基因型数据,评估补体C4A、C4B和HERV-K拷贝数变异与血管炎风险的关联。结果显示,与其他免疫介导炎症性疾病不同,较高的C4拷贝数增加GCA和IgAV风险,且存在性别偏倚,这些关联独立于经典HLA等位基因。
要点
- 男性GCA患者中较高的C4B拷贝数增加疾病风险(OR 1.23)。
- IgAV整体队列中较高的C4A拷贝数与疾病易感性显著相关(OR 1.68)。
- C4拷贝数变异与GCA和IgAV的关联独立于经典HLA等位基因。
核心结论
- 补体C4拷贝数变异是GCA和IgAV的新型遗传风险因素,且呈现性别依赖性。
研究设计与样本
- 研究纳入3498例GCA患者、284例IgAV患者和16867例对照,从基因型数据推断C4A、C4B和HERV-K拷贝数,并评估其与血管炎风险的关联。
主要发现
- 在GCA中,较高的C4B拷贝数在男性患者中 confer 风险(OR 1.23,95%CI 1.07-1.42,P=4.52×10-3,PFDR=1.40×10-2)。
- 在IgAV中,较高的C4A拷贝数与整体队列疾病易感性显著相关(OR 1.68,95%CI 1.22-2.30,P=1.49×10-3,PFDR=4.48×10-3)。
- 在IgAV中,C4B拷贝数呈现男性偏倚趋势(OR 1.46,95%CI 1.02-2.08,P=3.88×10-2,PFDR=5.80×10-2)。
- 条件分析证实这些关联独立于经典HLA等位基因。
关键数值与推荐
- GCA男性患者C4B拷贝数每升高一个单位,风险增加(OR 1.23,95%CI 1.07-1.42)。
- IgAV整体队列C4A拷贝数每升高一个单位,风险增加(OR 1.68,95%CI 1.22-2.30)。
- IgAV男性患者C4B拷贝数每升高一个单位,风险增加趋势(OR 1.46,95%CI 1.02-2.08)。
临床怎么用
- 对于疑似GCA或IgAV的患者,补体C4基因拷贝数变异可能作为遗传风险标志物,尤其需考虑性别差异。
- 该发现提示补体失调在GCA和IgAV发病中起作用,可能为未来靶向治疗提供线索。
局限性
- 研究为遗传关联分析,未验证功能机制。
- IgAV样本量较小(284例),需更大队列验证。
- 拷贝数通过推断而非直接测量获得。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Low copy number (CN) of complement C4 isoforms and high CN of retroviral HERV-K elements are known risk factors for many immune-mediated inflammatory diseases (IMIDs), often showing sex-biased effects. Here, we assessed whether CN variation within the C4 gene contributes to giant cell arteritis (GCA) and IgA vasculitis (IgAV), two complex vasculitides involving complement dysregulation. METHODS: C4A, C4B, and HERV-K CNs were imputed from genotypic data of 3,498 patients with GCA, 284 patients with IgAV, and 16,867 controls. We evaluated their associations with vasculitis risk overall and stratified by sex (inferred from genetic data), alongside classical HLA alleles. RESULTS: Contrary to other IMIDs, we identified higher C4 CN to confer risk to GCA and IgAV. Specifically, in GCA, higher C4B CN conferred risk in male patients (odds ratio (OR) 1.23, 95% confidence interval (CI) 1.07-1.42, P = 4.52 × 10-3, P adjusted by false discovery rate (PFDR) = 1.40 × 10-2). In IgAV, elevated C4A CN was significantly associated with disease susceptibility in the overall cohort (OR 1.68, 95% CI 1.22-2.30, P = 1.49 × 10-3, PFDR = 4.48 × 10-3), whereas C4B CN showed a male-biased trend, as observed in GCA (OR 1.46, 95% CI 1.02-2.08, P = 3.88 × 10-2, PFDR = 5.80 × 10-2). Conditional analyses confirmed that these associations were independent of classical HLA alleles. CONCLUSION: This study reveals sex-dependent variation in C4 CN as a novel genetic risk factor for GCA and IgAV, suggesting shared biologic mechanisms involving complement dysregulation, sustained inflammation, and vascular damage.
引用
- Martínez-Gutiérrez L, Borrego-Yaniz G, Hernández-Rodríguez J, et al. Higher Complement C4 Gene Copy Number Constitutes a Shared Genetic Risk Factor for Giant Cell Arteritis and IgA Vasculitis. Arthritis Rheumatol. 2026. PMID: 42045811. doi:10.1002/art.70203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。